However, the prognosis of ESCC patients with high expression of both Nrf2 and CaMKIIα was worse than that of ESCC patients with low expression of Nrf2 and high expression of CaMKIIα (Fig. 10d). This evidence concerns the gene NFE2L2 and esophageal squamous cell carcinoma.